Aggressive systemic mastocytosis

Joint Bone Spine

Volumn 70, Issue 1, 2003, Pages 64-66

  Inaoui, Rachida ^a   Petit, Barbara ^a   Jaccard, Arnaud ^a   Bertin, Philippe ^a   Trèves, Richard ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

C kit; Immunohistochemistry; Interferon; Osteoporosis; Systemic mastocytosis

Indexed keywords

ALENDRONIC ACID; ALPHA INTERFERON; C REACTIVE PROTEIN; PREDNISONE;

ACUTE MYELOBLASTIC LEUKEMIA; AGED; ARTICLE; ASTHENIA; BONE MARROW BIOPSY; BONE MINERALIZATION; CASE REPORT; DIAGNOSTIC TEST; DISEASE SEVERITY; FEMALE; FEMUR NECK FRACTURE; GIANT CELL ARTERITIS; HEMATOLOGIC DISEASE; HISTOLOGY; HUMAN; INFLAMMATION; LABORATORY TEST; MAST CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; OSTEOSARCOMA; SARCOMA; SMEAR; STAINING; STERNUM; SYMPTOM; SYSTEMIC MASTOCYTOSIS;

AGED; ALENDRONATE; BONE MARROW CELLS; FATAL OUTCOME; FEMALE; HUMANS; INTERFERON-ALPHA; LEUKEMIA, MYELOCYTIC, ACUTE; MAST CELLS; MAST-CELL SARCOMA; MASTOCYTOSIS, SYSTEMIC; NEOPLASMS, MULTIPLE PRIMARY; OSTEOPOROSIS, POSTMENOPAUSAL; PREDNISONE; SERINE ENDOPEPTIDASES; TRYPTASES;

EID: 0037300240     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1297-319X(02)00015-5     Document Type: Article

References (17)

1. de Vernejoul MC, de Gennes C. Mastocytose osseuse; l'actualité rhumatologique. Expansion Scientifique Française 1991-130-6.
2. Lortholary O, Casassus Ph, Laroche L, Lortholary P, Diebold J. Mastocytose systémique et mastocytoses malignes. La l'resse Médicale 27 Janvier 1990;vol. 19(No. 3):125-8.
3. Bridget Wilkins S, Barbara J, Bain. Normal and neoplastic mast cells. Br J Haematol 1999;106(1):9-17.
4. Avila NA, Ling A, Metcalfe DD, Worobec AS. Mastocytosis: magnetic resonance imaging patterns of marrow disease. Skeletal Radiol 1998;27:119-26.
5. Marshall A, Kavanagh RT, Crisp AJ. The effect of pamidronate on lumbar spine bone density and pain in osteoporosis secondary to systemic mastocytosis. Br J Rheumatol 1997;36:393-6.
6. King PHM, Hutchinson RM. Blood findings in generalized mastocytosis: coexistent non-Hodgkin's lymphoma. Br J Haematol 1991;77:436-42.
7. Horny HP, Sillaber C, Menke D, Kaiserling E, Wehrmann M, Stehberger B, et al. Diagnostic value of immunostaining for tryptase in patients with mastocytosis. Am J Sur Pathol 1998;22:1132-40.
8. Bazex A, Dupré A, Christol B, Andrieu H. Les mastocytoses familiales. Annales de dermatologie et de syphyligraphie; Paris 1971;vol. 98(No. 3):241-60.
9. Trèves R, Leboutet MJ. Encycl. Med. Chir (Paris): Appareil locomoteur, 14027, G20, 6-1985, 14,40,2032.
10. Pignon J, Giraudier S, Duquesnoy P, Jouault H, Imbert M, Vainchenker W, et al. A new c-kit mutation in a case of aggressive mast cell disease. Br J Haematol 1997;96:374-6.
11. Hanneke C, Klein-Nelemans M. Response to interferon a-2h in a patient with systemic mastocytosis. NEJM Feb 27 1992;326(9).
12. Frank Austen K. Systemic mastocytosis. N Engl J Med Feb 27 1992; 326(9):639-40.
13. Fain O, Sitbon M. Efficacité de l'interféron Æ dans un cas de mastocytose systémique. Annales de Médecine Interne 1995;146:205-6.
14. Harrison BD, Ashford RA, Hatton CS. Systemic Mastocytosis, a case treated with interferon a and radiotherapy. Clin Lab Haematol Sept 1994;16(3):291-4.
15. Johnstone PA, Mican JM, Metcalfe DD, De Laney, TF. Radiotherapy of refractory bone pain due to systemic mast cell disease. Am J Clin Oncol Aug 1994;17(4):328-30.
16. Brian Druker J, Moshe Talpaz, Debra Resta J, Bin Peng RN, Elisabeth Buchdunger, John Ford M, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 5 April 2001;334(14):1031-7.
17. Brian Druker J, Charles Sawyers L, Hagop Kantarjian, Debra Resta J, Soña Fernandes Reese RN, John Ford, et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisi of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 5 April 2001;344(14):1038-42.